Isolation and enzymatic characterization of a basic phospholipase A2 from Bothrops jararacussu snake venom. 2001

V L Bonfim, and M H Toyama, and J C Novello, and S Hyslop, and C R Oliveira, and L Rodrigues-Simioni, and S Marangoni
Departamento de Bioquímica, Instituto de Biologia, Universidade Estadual de Campinas, SP, Brazil.

A novel basic phospholipase A2 (PLA2) isoform was isolated from Bothrops jararacussu snake venom and partially characterized. The venom was fractionated by HPLC ion-exchange chromatography in ammonium bicarbonate buffer, followed by reverse-phase HPLC to yield the protein Bj IV. Tricine SDS-PAGE in the presence or absence of dithiothreitol showed that Bj IV had a molecular mass of 15 and 30 kDa, respectively. This enzyme was able to form multimeric complexes (30, 45, and 60 kDa). Amino acid analysis showed a high content of hydrophobic and basic amino acids as well as 14 half-cysteine residues. The N-terminal sequence (DLWSWGQMIQETGLLPSYTTY...) showed a high degree of homology with basic D49 PLA2 myotoxins from other Bothrops venoms. Bj IV had high PLA2 activity and produced moderate myonecrosis in skeletal muscle, but showed no neuromuscular activity in mouse phrenic nerve-diaphragm preparations. Bj IV showed allosteric enzymatic behavior, with maximal activity at pH 8.2 and 35-45 degrees C. Full PLA2 activity required Ca2+ but was inhibited by Cu2+ and Zn2+, and by Cu2+ and Mg2+ in the presence and absence of Ca2+, respectively. Crotapotins from Crotalus durissus terrificus rattlesnake venom significantly inhibited the enzymatic activity of Bj IV. The latter observation suggested that the binding site for crotapotin in this PLA2 was similar to that in the basic PLA2 of the crotoxin complex from C. d. terrificus venom. The presence of crotapotin-like proteins capable of inhibiting the catalytic activity of D49 PLA2 could partly explain the low PLA2 activity of Bothrops venoms.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D003435 Crotalid Venoms Venoms from snakes of the subfamily Crotalinae or pit vipers, found mostly in the Americas. They include the rattlesnake, cottonmouth, fer-de-lance, bushmaster, and American copperhead. Their venoms contain nontoxic proteins, cardio-, hemo-, cyto-, and neurotoxins, and many enzymes, especially phospholipases A. Many of the toxins have been characterized. Bothrops Venom,Crotalidae Venoms,Pit Viper Venoms,Rattlesnake Venoms,Crotactin,Crotalid Venom,Crotalin,Crotaline Snake Venom,Crotalotoxin,Crotamin,Pit Viper Venom,Rattlesnake Venom,Snake Venom, Crotaline,Venom, Bothrops,Venom, Crotalid,Venom, Crotaline Snake,Venom, Pit Viper,Venom, Rattlesnake,Venoms, Crotalid,Venoms, Crotalidae,Venoms, Pit Viper,Venoms, Rattlesnake,Viper Venom, Pit
D003439 Crotoxin A specific complex of toxic proteins from the venom of Crotalus durissus terrificus (South American rattlesnake). It can be separated into a phospholipase A and crotapotin fragment; the latter consists of three different amino acid chains, potentiates the enzyme, and is specifically neurotoxic. Crotapotin,Crotoxin A,Crotoxin B
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino

Related Publications

V L Bonfim, and M H Toyama, and J C Novello, and S Hyslop, and C R Oliveira, and L Rodrigues-Simioni, and S Marangoni
October 2003, Biochimie,
V L Bonfim, and M H Toyama, and J C Novello, and S Hyslop, and C R Oliveira, and L Rodrigues-Simioni, and S Marangoni
September 2011, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP,
V L Bonfim, and M H Toyama, and J C Novello, and S Hyslop, and C R Oliveira, and L Rodrigues-Simioni, and S Marangoni
August 2004, Toxicon : official journal of the International Society on Toxinology,
V L Bonfim, and M H Toyama, and J C Novello, and S Hyslop, and C R Oliveira, and L Rodrigues-Simioni, and S Marangoni
August 1995, Journal of molecular evolution,
V L Bonfim, and M H Toyama, and J C Novello, and S Hyslop, and C R Oliveira, and L Rodrigues-Simioni, and S Marangoni
January 2011, Current topics in medicinal chemistry,
V L Bonfim, and M H Toyama, and J C Novello, and S Hyslop, and C R Oliveira, and L Rodrigues-Simioni, and S Marangoni
October 1992, Archives of biochemistry and biophysics,
V L Bonfim, and M H Toyama, and J C Novello, and S Hyslop, and C R Oliveira, and L Rodrigues-Simioni, and S Marangoni
July 2016, International immunopharmacology,
V L Bonfim, and M H Toyama, and J C Novello, and S Hyslop, and C R Oliveira, and L Rodrigues-Simioni, and S Marangoni
January 2002, Journal of protein chemistry,
V L Bonfim, and M H Toyama, and J C Novello, and S Hyslop, and C R Oliveira, and L Rodrigues-Simioni, and S Marangoni
January 2000, The international journal of biochemistry & cell biology,
V L Bonfim, and M H Toyama, and J C Novello, and S Hyslop, and C R Oliveira, and L Rodrigues-Simioni, and S Marangoni
January 2006, Protein and peptide letters,
Copied contents to your clipboard!